---
title: "KHAN SAMINA — Ownership Dossier"
canonical: https://whiteintel.dev/entity/bbcd5602-eda7-5a1a-a5dc-2b74408abdec
json: https://whiteintel.dev/api/public/dossier/bbcd5602-eda7-5a1a-a5dc-2b74408abdec
identifier: sec:0001903865
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# KHAN SAMINA

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001903865`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/bbcd5602-eda7-5a1a-a5dc-2b74408abdec  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/bbcd5602-eda7-5a1a-a5dc-2b74408abdec  

## Ownership & control

### Holdings / subsidiaries

- **REATA PHARMACEUTICALS INC** (officer) — https://whiteintel.dev/entity/79b77db8-6272-5c47-84af-cde1815ff368

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **KHAN SAMINA**. Human view: https://whiteintel.dev/entity/bbcd5602-eda7-5a1a-a5dc-2b74408abdec · Structured JSON: https://whiteintel.dev/api/public/dossier/bbcd5602-eda7-5a1a-a5dc-2b74408abdec._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._